IL18 and Eczematoid dermatitis: Both the analyses of IL-18 on IBD (Fig. 2) and on eczema/dermatitis (Supplementary Material, Fig. S2) survived leave-one-out analyses (Supplementary Material, Table S5), as the removal of any individual SNP from the analysis had little effect on observed effect estimates.